A detailed history of Bain Capital Life Sciences Investors, LLC transactions in Cabaletta Bio, Inc. stock. As of the latest transaction made, Bain Capital Life Sciences Investors, LLC holds 2,760,888 shares of CABA stock, worth $5.16 Million. This represents 2.34% of its overall portfolio holdings.

Number of Shares
2,760,888
Previous 1,649,964 67.33%
Holding current value
$5.16 Million
Previous $12.3 Million 5.59%
% of portfolio
2.34%
Previous 2.52%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$3.94 - $8.24 $4.38 Million - $9.15 Million
1,110,924 Added 67.33%
2,760,888 $13 Million
Q2 2024

Aug 12, 2024

BUY
$7.22 - $18.82 $235,372 - $613,532
32,600 Added 2.02%
1,649,964 $12.3 Million
Q1 2024

May 15, 2024

SELL
$16.79 - $25.38 $6.42 Million - $9.71 Million
-382,636 Reduced 19.13%
1,617,364 $27.6 Million
Q2 2023

Aug 14, 2023

BUY
$7.65 - $13.95 $15.3 Million - $27.9 Million
2,000,000 New
2,000,000 $25.8 Million

Others Institutions Holding CABA

About Cabaletta Bio, Inc.


  • Ticker CABA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,014,000
  • Market Cap $54.3M
  • Description
  • Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...
More about CABA
Track This Portfolio

Track Bain Capital Life Sciences Investors, LLC Portfolio

Follow Bain Capital Life Sciences Investors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bain Capital Life Sciences Investors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bain Capital Life Sciences Investors, LLC with notifications on news.